If you've been told you have "fatty liver disease" and don't drink much alcohol, you might have felt confused about how that's even possible. In 2023, doctors officially renamed this condition, and the new name actually explains a lot, including why it's showing up so often alongside high cholesterol.
A New Name With a Real Reason Behind It
The condition long known as non-alcoholic fatty liver disease, or NAFLD, has a new official name: metabolic dysfunction-associated steatotic liver disease, or MASLD. This wasn't just a cosmetic rebrand. A group of international liver specialists went through a formal consensus process and decided the old name had two real problems. First, defining the disease by what it isn't, alcohol related, never explained what it actually is. Second, the word "fatty" carried a stigma that many patients found discouraging or even shaming, without adding any medical value.
The new name fixes both issues by naming the real driver directly: metabolic dysfunction. That single word change is the whole point of this article, because it puts fatty liver disease in the same family as the conditions we've covered extensively on this site, insulin resistance, metabolic syndrome, and dyslipidemia.
How Common Is This, Actually?
Far more common than most people realize. Global estimates suggest MASLD affects somewhere between 25 and 38 percent of the general population, and researchers project that by 2030, roughly one third of people worldwide will have it. Within specific higher risk groups, the numbers climb sharply: about 65 percent of people with obesity have it, 55 percent of people with type 2 diabetes have it, and among people with dyslipidemia, that figure rises as high as 72 percent.
That last statistic is worth sitting with. If you already have an unhealthy cholesterol or triglyceride profile, there's a genuinely high chance your liver is quietly involved too, whether or not anyone has mentioned it to you. Part of what makes this tricky is that MASLD in its early stages rarely causes pain or any obvious warning sign, so it tends to be discovered by accident rather than because someone went looking for it.
Why Your Liver and Your Cholesterol Are So Tangled Together
Think of your liver like a warehouse that's constantly handling fat. Fat comes in the front door (from food you eat, and from fat your liver makes on its own), and fat is supposed to go out the back door (burned for energy, or packaged up and shipped out into your bloodstream).
In MASLD, more fat keeps coming in the front door than the liver can burn off or ship out fast enough. The warehouse starts backing up, and fat builds up inside the liver itself. To relieve some of that pressure, the liver starts shipping out more packages than usual, specifically packages called VLDL, which are loaded heavily with triglycerides. Once these VLDL packages are out in your bloodstream, they eventually get broken down and converted into LDL cholesterol, the same LDL we've talked about throughout this site. So a backed-up liver doesn't just sit there quietly, it actively pushes more fat particles into your blood, which is exactly why MASLD and unhealthy cholesterol numbers, especially high triglycerides, tend to show up in the same people.
There's a second piece that makes this worse over time. All that extra fat sitting inside liver cells makes it harder for those cells to respond normally to insulin. And when the liver becomes more insulin resistant, it tends to ship out even more of those triglyceride-loaded VLDL packages. So you end up with a loop: a backed-up liver leads to insulin resistance, and insulin resistance leads to even more fat particles getting pushed into your blood. This is exactly why doctors now treat MASLD and unhealthy cholesterol as two symptoms of the same underlying problem, rather than two separate issues that just happen to show up in the same people.
It's Not Just a Liver Problem
Here's something that surprises a lot of people: MASLD itself has been linked to a higher risk of heart-related complications, including coronary artery disease, irregular heart rhythms like atrial fibrillation, and thickening of the heart muscle that can eventually contribute to heart failure. In other words, this isn't a condition that stays contained to the liver while your cardiovascular system watches from the sidelines. The same metabolic dysfunction driving fat accumulation in your liver is simultaneously working against your heart.
Quick Reference
| Group | Approximate MASLD Prevalence |
|---|---|
| General adult population | 25-38% |
| People with obesity | ~65% |
| People with type 2 diabetes | ~55% |
| People with dyslipidemia | Up to 72% |
What Actually Helps
Since MASLD is rooted in the same metabolic dysfunction behind insulin resistance and unhealthy cholesterol patterns, the most effective approach addresses that shared root cause rather than treating the liver as an isolated problem. Weight management, reducing added sugar and refined carbohydrates, regular physical activity, and improving insulin sensitivity are consistently the foundation of managing MASLD, and these are the same habits that tend to improve triglycerides and small, dense LDL patterns at the same time. This is a case where treating the whole metabolic picture genuinely helps more than trying to treat any single number in isolation.
Frequently Asked Questions
Q: How would I even know if I have MASLD?
It's often discovered incidentally, through an ultrasound or blood test done for another reason, since early MASLD typically causes no noticeable symptoms. If you have risk factors like obesity, type 2 diabetes, or an unhealthy lipid panel, it's reasonable to ask your doctor whether liver screening makes sense for you.
Q: Does this mean fatty liver disease and high cholesterol are basically the same thing?
Not exactly the same thing, but closely connected. They share the same underlying metabolic dysfunction and often show up together, which is why doctors increasingly look at them as part of one connected picture rather than two unrelated results on a chart.
Q: If I don't drink alcohol at all, why would my doctor even suspect a liver issue?
This is exactly the confusion the renaming was meant to clear up. MASLD has nothing to do with alcohol consumption, it's driven by metabolic factors like obesity, insulin resistance, and dyslipidemia, which is precisely why the old alcohol-focused name was misleading in the first place.
Key Takeaway
The renaming of fatty liver disease to MASLD in 2023 wasn't just about removing stigma, it was about accurately naming the real cause: metabolic dysfunction, the same root issue behind insulin resistance, metabolic syndrome, and unhealthy cholesterol patterns we've covered throughout this site. With up to 72 percent of people with dyslipidemia affected, and real cardiovascular risk attached to the condition itself, this is a strong reminder that your liver, your lipid panel, and your heart are far more connected than a standard cholesterol test alone would ever suggest.
References
- Lake-Bakaar G. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): New Perspectives on an Evolving Epidemic. Journal of Clinical Medicine. 2025;14(24):8872. doi.org/10.3390/jcm14248872
- Feng X, Zhang R, Yang Z, Zhang K, Xing J. Mechanism of Metabolic Dysfunction-Associated Steatotic Liver Disease: Important Role of Lipid Metabolism. Journal of Clinical and Translational Hepatology. 2024;12(9):815-826. doi.org/10.14218/JCTH.2024.00019
- Cardiovascular Disease in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Comprehensive Narrative Review. ncbi.nlm.nih.gov/pmc/articles/PMC12692567